Securities Code: 002332 Securities Abbreviation: Xinfu Pharmaceutical Announcement No.: 2026-007
Zhejiang Xinfu Pharmaceutical Co., Ltd. 2025 Profit Distribution Plan
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed, and that there are no false records, misleading statements, or material omissions.
I. Deliberation Procedures
Zhejiang Xinfu Pharmaceutical Co., Ltd. (hereinafter referred to as the "Company") held the Second Meeting of the Ninth Board of Directors on April 21, 2026. The proposal "Company 2025 Profit Distribution Plan" was deliberated and approved by a vote of 9 in favor, 0 against, and 0 abstentions. This proposal is subject to the approval of the 2025 Annual General Meeting of Shareholders.
II. Basic Information of the Profit Distribution Plan
(I) Basic Content of the Current Profit Distribution Plan
- The current profit distribution plan is for the 2025 profit distribution.
- According to the "Audit Report" [2026] No. ZF10434 issued by Lixin Certified Public Accountants (Special General Partnership), in 2025, the Company achieved a net profit of RMB 452,603,660.56, and the net profit attributable to the parent company's shareholders was RMB 449,640,395.37. In 2025, the net profit realized by the parent company was RMB 315,000,416.59. A legal reserve of 10% of the net profit realized by the parent company, amounting to RMB 31,500,041.66, was withdrawn. Adding the undistributed profit at the beginning of the year, RMB 1,602,528,734.35, and deducting the cash dividends distributed for 2024 and the first half of 2025, RMB 395,681,946.40, the undistributed profit at the end of the period on the consolidated financial statements was RMB 2,650,162,418.24, and the undistributed profit of the parent company was RMB 1,490,347,162.88. According to the principle of taking the lower of the undistributed profit on the consolidated financial statements and the parent company's financial statements, the profit actually available for distribution to shareholders at the end of the period was RMB 1,490,347,162.88. The share capital at the end of the period was 989,204,866 shares.
- Company's 2025 cash dividend ratio and estimated total dividend:
- 2025 Interim Cash Dividend Plan: Based on the total share capital of 989,204,866 shares as of June 30, 2025, a cash dividend of RMB 1 (tax inclusive) per 10 shares will be distributed, totaling RMB 98,920,486.60. The Company published the "Announcement on the Implementation of the 2025 Interim Dividend Distribution Plan" on October 15, 2025, and completed the distribution on October 22, 2025. (2) Company's 2025 Profit Distribution Plan: Based on the total share capital of 989,204,866 shares as of December 31, 2025, a cash dividend of RMB 2 (tax inclusive) per 10 shares will be distributed, totaling RMB 197,840,973.20. The remaining undistributed profit will be carried forward to subsequent periods. No bonus shares will be issued, nor will capital reserves be capitalized for new shares in 2025. (3) If the current profit distribution plan is approved by the 2025 Annual General Meeting of Shareholders, the Company's cumulative cash dividend for 2025 will be RMB 296,761,459.80, accounting for 66.00% of the net profit attributable to shareholders of the listed company for the current year.